secwatch.observer — SEC 8-K summary
======================================

Issuer:     DNA X, Inc. (SONM)
CIK:        0001178697
Form:       8-K
Filed at:   2026-05-20T20:50:16+00:00
Accession:  0001493152-26-024639
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

DNA X Q1 2026: asset sale nets $6.3M; no continuing revenue; raises $1.8M debt
------------------------------------------------------------------------------

- Completed sale of mobile device assets to NEXA for $15M (net $13.5M after working capital adj); $12M paid, $1.5M due Oct 2026.
- Net income of $6.3M from asset sale (taxes, fees, severance); no revenue from continuing operations.
- G&A expenses from continuing ops $3.6M, including $1.5M severance and $0.9M audit/tax costs.
- Cash from continuing ops $1.2M at quarter end; entered agreement for $1.8M new debt on May 20, 2026.
- Rebranded from Sonim Technologies to DNA X, Inc.; focuses on AI/crypto trading platform.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1178697/000149315226024639/0001493152-26-024639-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1178697/000149315226024639/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-024639

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer